Dallas, TX · Source-checked provider directory

Peptide clinics in Dallas, TX.
Compare providers before you book.

Compare Dallas clinics that publicly list peptide therapy, then verify the prescriber, medication status, pharmacy, costs, and follow-up plan before booking. We do not sell peptides or recommend a specific treatment.

Why peptides · why now

Compare Dallas providers by verifiable details.

Dallas-Fort Worth is one of the largest concierge medicine markets in the country. The corridor that runs from Park Cities through Preston Hollow up toward Plano and Frisco has been quietly building age-management and hormone-optimization protocols for two decades. Executive practices around Uptown, Knox-Henderson, and the Stemmons corridor see a steady stream of high-performing patients in their forties and fifties who are already running labs annually and treating the GH/IGF-1 axis as a domain worth understanding. What is changing now is the federal regulatory frame around growth-hormone-axis peptides, and the Dallas clinics that have been waiting on a clean legal lane are about to get one.

The short version: in 2023 the FDA placed several named peptides (BPC-157, KPV, TB-500, MOTs-C, and others) into Category 2 of the 503A bulk substances list, which restricts but does not prohibit compounding. On April 16, 2026 a Federal Register notice reopened the nominations process. The Pharmacy Compounding Advisory Committee (PCAC) is scheduled to meet July 23–24, 2026 to review the science and vote on whether those compounds move into Category 1 (clearly compoundable under 503A) or stay in Category 2. Whatever the committee decides, Dallas providers preparing for that meeting may be in a different position afterward.

Regulatory status depends on the exact product, intended use, prescriber, and dispensing pharmacy. FDA's July 2026 meeting agenda discusses specified nominated bulk substances; it is not a blanket authorization or an approval of a particular prescription. Read the FDA agenda, then ask the clinician and pharmacy to explain the current requirements for the exact product under discussion.

Patient questions · Anti-aging and longevity

Understand the exact product before you decide.

Dallas peptide searches often center on anti-aging and longevity. The examples below are discussion starters, not treatment recommendations. Regulatory status, evidence, and availability vary by product and intended use; confirm the exact details with a licensed clinician and dispensing pharmacy.

Sermorelin
GHRH analog · pulsatile GH

A growth-hormone-releasing hormone analog. It prompts the pituitary to release endogenous growth hormone in its natural pulse pattern rather than supplying exogenous GH directly. Well-established history of clinical use. Generally well-tolerated in adults under physician supervision.

Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006. PMC2699646

Tesamorelin
GHRH analog · visceral fat · liver

FDA-approved as Egrifta for HIV-associated lipodystrophy. Also studied in non-HIV populations for visceral adiposity and non-alcoholic fatty liver disease. Dallas executive-health practices discuss it widely for central adiposity in patients over forty-five.

Stanley TL, et al. Effects of tesamorelin on visceral fat and liver fat. JAMA. PMC8366828

GHK-Cu
Copper tripeptide · skin · regenerative

A copper-binding tripeptide naturally present in human plasma. Levels decline with age. Shows activity on wound healing, dermal collagen, and gene expression patterns in younger tissue. Dallas aesthetic-adjacent longevity practices commonly compound it as a topical.

Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci. 2018. PMC6073405 · Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015. PMC4508379

BPC-157
BPC-157-related bulk substances

FDA's July 2026 agenda lists BPC-157-related bulk substances for discussion and identifies ulcerative colitis as the use evaluated in that agenda. A committee discussion does not establish that a product is approved, appropriate, or available for a different purpose. Ask the prescriber what product and use are being discussed and ask the pharmacy how it is sourced.

FDA PCAC meeting agenda, July 2026

Growth hormone axis (clinical context)
Endocrine · aging review

This 2025 clinical review is the best summary of the current evidence base on the GH/IGF-1 axis in aging. Read it before your first consult if you want to understand why so much of peptide work circles back to growth-hormone-releasing signals. See our Oklahoma City directory for a parallel doctor-authority market with identical protocol patterns.

Bartke A. Growth hormone and aging: a clinical review. 2025. PMC12009952

How to find a clinic in Dallas

The questions that actually separate a real clinic from a storefront.

Three or four questions, asked in this order, will tell you within ten minutes whether a Dallas provider is operating under federal compounding law or is something you should walk away from. Dallas is large enough that you will see both kinds. The screen is straightforward.

Which 503A pharmacy fills your prescriptions?
A legitimate Dallas clinic will name the pharmacy without hesitation. Usually it's a Texas-licensed or out-of-state 503A facility with a documented prescriber relationship. Verify the license through the Texas State Board of Pharmacy in about two minutes. If the answer is "we keep our supply in-house," that is a 503B, a research-chemical reseller, or worse. Walk away.
Will you run baseline bloodwork before prescribing?
For anything in the growth-hormone axis the answer must be yes. At minimum: comprehensive metabolic panel, IGF-1, a hormone panel relevant to your sex and age, and inflammatory markers. A clinic that writes a sermorelin or tesamorelin script without baseline labs is not practicing medicine. It's running a subscription. For a comparison of how other doctor-authority markets handle baseline workup, see our Nashville, TN directory.
What does the follow-up cadence look like?
Six-to-twelve week re-labs are the standard of care for GH-axis peptides. Clinics that hand you a six-month supply with no scheduled follow-up are not the ones you want. Good Dallas practices structure this as a clinical relationship, not a transaction.
How do you handle the July 2026 PCAC review?
A clinic worth your time is tracking the Federal Register and PCAC agenda directly and can explain to you, in plain language, what changes if BPC-157, KPV, TB-500, or MOTs-C move out of Category 2 and what stays the same. If they cannot answer that question, they are not paying attention to the law that governs their own practice.
Verified Dallas clinics

Practitioners we've confirmed.

Editorial listing, not an endorsement or paid placement. Service availability can change. Confirm the treating prescriber, current state-license status, medication approval status, dispensing pharmacy, total cost, and follow-up plan directly with the clinic.

Is this your clinic? Activate your listing to add website, phone, and patient actions
Priority Access · Dallas, TX

Get matched as the Dallas directory grows.

Join the Dallas list

Be first in line for verified Dallas peptide clinics.

This patient form is for people seeking care. Clinic applications go through the separate listing form above. No spam. Unsubscribe anytime.

We do not prescribe, dispense, or ship peptides.

Straight Answers · Dallas

What you should know before joining the Dallas list.

What is FDA reviewing in July 2026?
FDA's Pharmacy Compounding Advisory Committee is meeting July 23–24, 2026 to discuss whether certain BPC-157, KPV, TB-500, and MOTs-C bulk drug substances should be included on the 503A Bulks List. Committee advice is nonbinding and the meeting does not itself authorize a particular product, prescription, or use. Ask a licensed clinician and pharmacy about the current requirements for your situation.
Will Find Peptide Clinics sell me peptides?
No. We do not sell peptides. Directory inclusion does not replace confirming the prescriber, exact product, approval or compounding status, pharmacy, cost, and follow-up plan.
What does a peptide clinic in Dallas actually do?
A legitimate Dallas peptide clinic conducts a full intake, runs baseline labs (CMP, IGF-1, hormone panel, inflammatory markers), discusses goals and contraindications, and only then writes a prescription that a partnered 503A pharmacy compounds patient-specific. Follow-up labs are scheduled at six to twelve weeks. The clinic does not stock vials. See our Charlotte, NC directory for a parallel example.
How do I know a Dallas clinic is legitimate?
Three checks. First, ask which 503A pharmacy fills their prescriptions and verify that pharmacy's license through the Texas State Board of Pharmacy. Second, confirm the prescriber's Texas medical license through the Texas Medical Board lookup. Third, ask whether they require baseline bloodwork before prescribing anything in the growth-hormone axis. If any answer is evasive, walk away.
Are the peptides themselves FDA-approved?
Most peptides discussed in anti-aging contexts are not FDA-approved as finished drug products for the indications patients ask about. They are compounded pursuant to a valid prescription by a 503A pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act. Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy and is sometimes prescribed off-label. Semaglutide is FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy).
How much does peptide therapy cost in Dallas?
Dallas cost ranges $300–$1,400 per month depending on peptide, pharmacy, and whether bloodwork is bundled. Park Cities and Preston Hollow concierge practices sit at the high end. Initial consult plus baseline labs runs $300–$800 separately. Insurance does not reimburse compounded peptides. For a deeper breakdown see our main FAQ.
Patient Guides

Check the clinic before you book.

Use these evidence-based checklists to verify the prescriber, exact product, dispensing pharmacy, complete price, follow-up plan, and records.